ClinicalTrials.govpublic full text
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
non-hodgkin's lymphoma, relapsed or refractory b cell non-hodgkin's lymphoma, chronic lymphoblastic leukemia, peripheral t cell lymphoma, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1031670
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.